Taysha Gene Therapies
TSHA
#6866
Rank
โ‚ฌ0.42 B
Marketcap
2,08ย โ‚ฌ
Share price
8.46%
Change (1 day)
30.54%
Change (1 year)

EPS for Taysha Gene Therapies (TSHA)

EPS in 2023 (TTM): -2,18ย โ‚ฌ

According to Taysha Gene Therapies's latest financial reports the company's current EPS (TTM) is -2,19ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -3,63ย โ‚ฌ an increase over its 2021 EPS that were of -4,42ย โ‚ฌ.

EPS history for Taysha Gene Therapies from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,18ย โ‚ฌ-39.87%
2022-3,63ย โ‚ฌ-17.93%
2021-4,42ย โ‚ฌ69.11%
2020-2,61ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-2,08ย โ‚ฌ-4.80%๐Ÿ‡บ๐Ÿ‡ธ USA